---
title: "Reishi mushroom and Zepbound | HealthRX.com"
description: "Zepbound is cleared by peptide breakdown, not CYP enzymes, and reishi did not impair clotting in 40 healthy volunteers. Liver case reports guide caution."
url: https://healthrx.com/supplements-zepbound/with-reishi
publisher: HealthRX.com
---


HealthRX.com quick answer. No interaction between reishi (Ganoderma lucidum) and Zepbound has been documented: the Zepbound label's drug interactions section names no dietary supplement, and no interaction study was found [1]. Tirzepatide is broken down by cleavage of its peptide backbone and by amide hydrolysis rather than by CYP enzymes [1], and one trial in 40 healthy volunteers found no impairment of hemostasis with reishi at 1.5 g/day for 4 weeks [2]. The caution worth carrying into this decision is reishi's own record: case reports of acute and fatal liver injury after reishi powder [3][4].

At a glance

- Interaction data / No reishi-tirzepatide interaction study found
- Bleeding / 1.5 g/day for 4 weeks did not impair hemostasis in 40 healthy volunteers [2]
- Liver / Case reports of hepatitis, one fatal, after reishi powder [3][4]
- Blood sugar / Cochrane review of 5 trials (3 analyzed, in [type 2 diabetes](https://healthrx.com/conditions-type-2-diabetes/diagnosis-algorithm)): no significant HbA1c change, -0.10% (95% CI -1.05 to 0.85) [5]
- Digestion / Tirzepatide delays gastric emptying; label advises monitoring narrow-therapeutic-index oral drugs such as warfarin [1]

## Reishi and Zepbound: the evidence base so far

Zepbound is a once-weekly subcutaneous GIP/GLP-1 receptor agonist approved, with a reduced-calorie diet and more physical activity, for weight reduction in adults with obesity or with overweight plus a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity [1]. Reishi is a mushroom sold in the US as an over-the-counter dietary supplement in powder, extract or capsule form, and a Drugs@FDA search for ganoderma returns no approved drug application [5][6]. The human research on it is small and short: 1.5 g/day for 4 weeks in a hemostasis trial, 2 g twice daily for 10 days in a safety trial, and 1.4 to 3 g/day for 12 to 16 weeks in diabetes trials. These are study doses, not recommended doses [2][7][5].

## Bleeding risk: the lab signal and the human trial

Reishi's reputation for thinning the blood rests mostly on laboratory work showing platelet inhibition. The randomized human test of that idea went the other way. Forty healthy volunteers took 1.5 g of Ganoderma lucidum capsules or placebo daily for 4 weeks in a double-blind trial; at 4 and 8 weeks there were no significant between-group differences on coagulation screen, fibrinogen, von Willebrand ristocetin cofactor activity, PFA-100 or thromboelastography, and all measurements remained within the normal range [2].

Those volunteers were healthy, not people on blood thinners, so the trial does not describe what happens when reishi meets an anticoagulant or antiplatelet drug. No human interaction study with those drugs was found.

[Tirzepatide](https://healthrx.com/products/tirzepatide) raises a separate drug-interaction point with warfarin. The Zepbound label says tirzepatide delays gastric emptying and can affect absorption of oral medicines, and it advises monitoring oral drugs that depend on threshold concentrations for efficacy and those with a narrow therapeutic index, naming warfarin [1]. The label describes this as an absorption issue: after a first 5 mg dose, acetaminophen peak concentration fell 55% and time to peak was 1 hour later, while at week 6 on 15 mg there was no meaningful effect on either, and total exposure was unchanged [1].

## Liver injury: the case reports behind the caution

Reishi's most concrete safety signal is hepatic. A fatal case of fulminant hepatitis followed 1 to 2 months of Ganoderma lucidum mushroom powder in a patient who had earlier taken boiled lingzhi without toxicity; a similar case was first described in a patient from Hong Kong in 2004, and both patients were taking other therapeutic agents [3][8]. A separate report describes a 47-year-old man who developed acute hepatitis with significant transaminitis after reishi powder together with alcohol, was treated with [N-acetylcysteine](https://healthrx.com/supplements-zepbound/with-nac) and intravenous fluids, and had complete resolution of symptoms and laboratory abnormalities at two-week follow-up [4].

On the other side, a double-blind placebo-controlled trial gave 16 healthy volunteers 2 g of reishi extract twice daily for 10 days and found no adverse effects on symptoms, ECG, complete blood counts, blood chemistry or urinalysis; the authors said a longer, dose-escalating safety trial was warranted [7].

## Reishi, glucose and the Zepbound hypoglycemia warning

Tirzepatide lowers glucose in a glucose-dependent way, and the label's hypoglycemia warning centers on people who also take insulin or an insulin secretagogue such as a sulfonylurea; the label says to consider reducing the dose of the other drug when starting Zepbound [1]. In SURMOUNT-2, glucose <54 mg/dL occurred in 10.3% of patients taking a sulfonylurea versus 2.1% of those not [1].

For reishi, a Cochrane review included 5 trials with 398 people; the three analyzed trials were in type 2 diabetes at 1.4 to 3 g/day for 12 to 16 weeks. It found no significant fall in HbA1c (-0.10%, 95% CI -1.05 to 0.85) and no significant effect on cholesterol, BMI, blood pressure or triglycerides. Adverse events were more likely with reishi (RR 1.67, 95% CI 0.86 to 3.24), but the difference was not significant and the events were not serious [5].

## Immune markers and immunosuppressant drugs

A Cochrane review of 5 cancer trials found that reishi added to chemotherapy or radiotherapy raised CD3, CD4 and CD8 cell percentages by 3.91%, 3.05% and 2.02% [9]. The same review rated the trials as poor in methodological quality, found that no trial recorded long-term survival, and concluded there was insufficient evidence to support reishi as a first-line cancer treatment [9]. Because reishi affects immune markers, a clash with immune-suppressing drugs is theoretical; no study testing reishi alongside immunosuppressant drugs was found.

## Gastric emptying and absorption

The Zepbound label states that the gastric-emptying delay is largest after the first dose and diminishes over time [1]. Tirzepatide itself has a half-life of about 5 days and reaches steady state after 4 weeks of once-weekly dosing [1].

## Reishi and Zepbound at a glance

Reishi has a thin human evidence base: short trials, no demonstrated effect on cardiovascular risk factors in people with type 2 diabetes [5], no hemostasis impairment in the one randomized bleeding study [2], and case reports of liver injury [3][4]. The Zepbound label points to monitoring oral drugs with a narrow therapeutic index such as warfarin, and to hypoglycemia when insulin or a sulfonylurea is also used [1].

Frequently asked questions

Can I take reishi mushroom while on Zepbound?

Reishi is a dietary supplement with no approved drug application [5][6], and its human trials are short: 4 weeks, 10 days, and 12 to 16 weeks at 1.4 to 3 g/day [2][7][5]. The Zepbound label's drug interactions section names no dietary supplement [1].

Does reishi thin the blood?

Laboratory work suggested it might. A double-blind trial in 40 healthy volunteers found no significant change in coagulation screen, fibrinogen, von Willebrand factor activity, PFA-100 or thromboelastography after 1.5 g/day for 4 weeks, with all values staying in the normal range [2]. That trial did not include people taking anticoagulant or antiplatelet drugs.

Can reishi hurt the liver?

Case reports describe a fatal fulminant hepatitis after 1 to 2 months of reishi powder, a Hong Kong case from 2004, and a 47-year-old man who developed acute hepatitis after reishi powder plus alcohol and recovered fully by two weeks [3][4][8]. A 10-day trial of 2 g twice daily in 16 healthy volunteers found no adverse effects on blood chemistry [7].

Does reishi lower blood sugar on tirzepatide?

A Cochrane review of 5 trials with 398 people (3 analyzed, all in type 2 diabetes) found no significant fall in HbA1c (-0.10%, 95% CI -1.05 to 0.85) and no significant change in cholesterol, BMI, blood pressure or triglycerides [5]. Tirzepatide's own hypoglycemia signal comes from insulin or sulfonylureas: in SURMOUNT-2, glucose <54 mg/dL occurred in 10.3% of patients taking a sulfonylurea versus 2.1% of those not [1].

Does delayed gastric emptying affect reishi absorption?

The label says tirzepatide delays gastric emptying, largest after the first dose and diminishing over time, and that this can change absorption of oral medicines [1]. No study of reishi absorption with tirzepatide was found.

Does reishi interact with immunosuppressant drugs?

A Cochrane review of 5 cancer trials found reishi added to chemotherapy or radiotherapy raised CD3, CD4 and CD8 cell percentages by 3.91%, 3.05% and 2.02% [9], and rated the trials poor in quality. A clash with immune-suppressing drugs is theoretical; no study testing reishi with immunosuppressant drugs was found.

References

Show all 9 references Hide references

1. U.S. National Library of Medicine, DailyMed. Zepbound injection (tirzepatide) prescribing information. [Zepbound injection (tirzepatide) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
2. Kwok Y, Ng KFJ, Li CCF, Lam CCK, Man RYK. [A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers](https://pubmed.ncbi.nlm.nih.gov/16037156/). Anesth Analg. 2005;101(2):423-426.
3. Wanmuang H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S. [Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder](https://pubmed.ncbi.nlm.nih.gov/17621752/). J Med Assoc Thai. 2007;90(1):179-81.
4. Guedikian R, Kim B, Singh G, Alexander R. [Ganoderma lingzhi (Reishi Mushroom)-Induced Acute Liver Injury in the Setting of Alcohol Use: A Case Report and Review of the Literature](https://pubmed.ncbi.nlm.nih.gov/37885515/). Cureus. 2023;15(9):e45953.
5. Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, et al. [Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors](https://pubmed.ncbi.nlm.nih.gov/25686270/). Cochrane Database Syst Rev. 2015;2015(2):CD007259.
6. [Drugs@FDA: FDA-Approved Drugs](https://www.accessdata.fda.gov/scripts/cder/daf/).
7. Wicks SM, Tong R, Wang CZ, O'Connor M, Karrison T, Li S, et al. [Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial](https://pubmed.ncbi.nlm.nih.gov/17597499/). Am J Chin Med. 2007;35(3):407-14.
8. Yuen MF, Ip P, Ng WK, Lai CL. [Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)](https://pubmed.ncbi.nlm.nih.gov/15464254/). J Hepatol. 2004;41(4):686-7.
9. Jin X, Ruiz Beguerie J, Sze DM, Chan GC. [Ganoderma lucidum (Reishi mushroom) for cancer treatment](https://pubmed.ncbi.nlm.nih.gov/27045603/). Cochrane Database Syst Rev. 2016;4(4):CD007731.

Next in this cluster

Related reading

- [tirzepatide Zepbound pharmacokinetics](https://healthrx.com/zepbound/pharmacokinetics)
- [tirzepatide Zepbound eGFR](https://healthrx.com/how-zepbound-affects/egfr)
- [tirzepatide Zepbound Hispanic / Latino Safety Profile Differences](https://healthrx.com/ethnicity-zepbound/hispanic-latino--safety-differences)
- [tirzepatide Zepbound cannabis interaction](https://healthrx.com/interactions-zepbound/cannabis-interaction)
- [tirzepatide Can I Take Resveratrol with Zepbound (Tirzepatide)?](https://healthrx.com/supplements-zepbound/with-resveratrol)
- [tirzepatide Tirzepatide saw palmetto interaction](https://healthrx.com/supplements-zepbound/with-saw-palmetto)
- [tirzepatide Can I Take St. John's Wort with Zepbound?](https://healthrx.com/supplements-zepbound/with-st-johns-wort)
- [tirzepatide Turmeric Zepbound](https://healthrx.com/supplements-zepbound/with-turmeric-curcumin)
- [tirzepatide Can I take vitamin B12 with Zepbound](https://healthrx.com/supplements-zepbound/with-vitamin-b12)
- [tirzepatide Can I take vitamin B6 with Zepbound](https://healthrx.com/supplements-zepbound/with-vitamin-b6)
- [tirzepatide Can I Take Vitamin D with Zepbound? A Clinical Review](https://healthrx.com/supplements-zepbound/with-vitamin-d)
- [tirzepatide Can I take zinc with Zepbound](https://healthrx.com/supplements-zepbound/with-zinc)
- [tirzepatide Zepbound safety signals](https://healthrx.com/zepbound/safety-signals-fda)
- [tirzepatide Zepbound and levothyroxine interaction](https://healthrx.com/interactions-zepbound/with-levothyroxine)

![reishi mushroom with zepbound: woman simmering dried reishi slices in a pot at home](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/supplements-zepbound/with-reishi.webp)

Reishi is often brewed as a tea, and liver and bleeding cautions matter alongside tirzepatide. Full reishi mushroom Zepbound guide and sources at [healthrx.com/supplements-zepbound](https://healthrx.com/supplements-zepbound).
